Abstract
Background: Single nucleotide polymorphisms (SNPs) may influence pain susceptibility and impact treatment response in pain-related temporomandibular disorders (TMDp). Objective: Explore the role of COMT (rs4646310, rs6269, rs4818, rs4680) and OPRM1 (rs1799971) genotypes in regulating treatment response. Methods: Sixty TMDp patients (55 females and 5 males), diagnosed with the Diagnostic Criteria for TMD (DC/TMD), underwent standardised treatment (information and education, home physical therapy, occlusal splint) for 6 months. Treatment outcomes included: pain intensity, pain-free mouth opening, jaw functional limitation, depression, and anxiety. Genotyping for COMT and OPRM1 SNPs was performed using DNA from buccal mucosa swabs and TaqMan assays. Statistical analysis was carried out to compare the changes in treatment outcomes and the influence of genotypes on treatment response. Results: Significantly less pain reduction was observed in minor allele carriers of rs4646310, and rs4680 compared to dominant homozygous (p
Author supplied keywords
Cite
CITATION STYLE
Zlendić, M., Vrbanović, E., Trošelj, K. G., Tomljanović, M., Đerfi, K. V., & Alajbeg, I. Z. (2024). Genetic influence on treatment outcomes in patients with pain-related temporomandibular disorders. Journal of Oral Rehabilitation, 51(8), 1542–1554. https://doi.org/10.1111/joor.13730
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.